Phospholipid-based Immobilized Artificial Membrane (IAM) Chromatography: A Powerful Tool to Model Drug Distribution Processes

被引:10
|
作者
Sobanska, Anna W. [1 ]
Brzezinska, Elzbieta [1 ]
机构
[1] Med Univ Lodz, Dept Analyt Chem, Ul Muszynskiego 1, PL-90151 Lodz, Poland
关键词
IAM chromatography; blood-brain barrier; skin permeability; oral bioavailability; BLOOD-BRAIN-BARRIER; PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN SERUM-ALBUMIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HUMAN INTESTINAL-ABSORPTION; STRUCTURALLY DIVERSE DRUGS; THIN-LAYER-CHROMATOGRAPHY; GRADIENT HPLC METHOD; PARTITION-COEFFICIENTS; POLAR INTERACTIONS;
D O I
10.2174/1381612823666171018114331
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A review of applications of the Immobilized Artificial Membrane (IAM) chromatography in drug discovery is given. IAM chromatography is presented as a tool to predict the interactions of solutes with biomembranes, blood-brain barrier permeability, volume of distribution, oral and skin absorption of drugs and compared to other in vitro techniques used to study drug bioavailability (caco-2 cells, liposome partition). Unbound phosphatidylcholine based stationary phases are also discussed. Some new trends and ideas in the IAM chromatography are presented.
引用
收藏
页码:6784 / 6794
页数:11
相关论文
共 50 条
  • [21] Affinity Chromatography: A Powerful Tool in Drug Discovery for Investigating Ligand/membrane Protein Interactions
    Lecas, Lucile
    Dugas, Vincent
    Demesmay, Claire
    SEPARATION AND PURIFICATION REVIEWS, 2021, 50 (03): : 315 - 332
  • [22] ISOLATION BY IMMOBILIZED ARTIFICIAL MEMBRANE CHROMATOGRAPHY (IAM-PC) AND PARTIAL IDENTIFICATION OF POTENT BILIARY CHOLESTEROL CRYSTALLIZATION INHIBITOR PROTEINS
    SECKNUS, R
    KRIVACIC, K
    CHERNOSKY, A
    JUVONEN, T
    HOLZBACH, RT
    HEPATOLOGY, 1995, 22 (04) : 22 - 22
  • [23] Immobilized liposome chromatography of drugs for model analysis of drug-membrane interactions
    Lundahl, P
    Beigi, F
    ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) : 221 - 227
  • [24] Immobilized artificial membrane chromatography with mass spectrometric detection: a rapid method for screening drug-membrane interactions
    Liu, H
    Carter, GT
    Tischler, M
    RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2001, 15 (17) : 1533 - 1538
  • [25] Hydrophobicity of HIV Protease Inhibitors by Immobilized Artificial Membrane Chromatography: Application and Significance to Drug Transport
    Barbra H. Stewart
    Francis Y. Chung
    Bradley Tait
    C. John
    O. Helen Chan
    Pharmaceutical Research, 1998, 15 : 1401 - 1406
  • [26] Hydrophobicity of HIV protease inhibitors by immobilized artificial membrane chromatography: Application and significance to drug transport
    Stewart, BH
    Chung, FY
    Tait, B
    John, C
    Chan, OH
    PHARMACEUTICAL RESEARCH, 1998, 15 (09) : 1401 - 1406
  • [27] Development of acidic phospholipid containing immobilized artificial membrane column to predict drug-induced phospholipidosis potency
    Wang, Jincai
    Zhao, Xianglong
    Xu, Dongsheng
    Lai, Liang
    Crommen, Jacques
    Guo, Jialiang
    Jiang, Zhengjin
    JOURNAL OF CHROMATOGRAPHY A, 2021, 1647
  • [28] How can we better realize the potential of immobilized artificial membrane chromatography in drug discovery and development?
    Tsantili-Kakoulidou, Anna
    EXPERT OPINION ON DRUG DISCOVERY, 2020, 15 (03) : 273 - 276
  • [29] Predicting drug penetration across the blood–brain barrier: comparison of micellar liquid chromatography and immobilized artificial membrane liquid chromatography
    Mike De Vrieze
    Frédéric Lynen
    Kai Chen
    Roman Szucs
    Pat Sandra
    Analytical and Bioanalytical Chemistry, 2013, 405 : 6029 - 6041
  • [30] Retention behavior of flavonoids on immobilized artificial membrane chromatography and correlation with cell-based permeability
    Tsopelas, Fotios
    Tsagkrasouli, Maria
    Poursanidis, Pavlos
    Pitsaki, Maria
    Vasios, George
    Danias, Panagiotis
    Panderi, Irene
    Tsantili-Kakoulidou, Anna
    Giaginis, Constantinos
    BIOMEDICAL CHROMATOGRAPHY, 2018, 32 (03)